Brexafemme (ibrexafungerp) is used to treat vaginal yeast infections in adults and pediatric females who have begun menstruating. Fact Table Formula C44H67N5O4 License US DailyMed Bioavailability - Legal status Rx-Only Chemical Name Ibrexafungerp Elimination half-life 20 hours Dosage (Strength) 150mg Pregnancy No serious adverse effects Brands Brexafemme Protein binding More than 99% PubChem CID 46871657 MedlinePlus a621039 ChEBI - ATC code None DrugBank DB12471 KEGG D11544 Routes of administration Oral

Brexafemme (Ibrexafungerp)

Brexafemme is available in 150 mg oral tablets. Follow the instructions that come with your Brexafemme prescription. Talk to your doctor or pharmacist about any questions or concerns you may have about your prescription. The recommended dosage is to take two tablets (300 mg) by mouth two times a day for one day with or without food. Take the two doses 12 hours apart. Before you begin taking Brexafemme, apregnancy testshould be obtained.
Before you begin treatment with Brexafemme, inform your doctor:, Of all the medications you take, including prescription and over-the-counter medications, vitamins, and herbal supplements, Of your allergies, Of your health problems, Of your pregnancy status. Brexafemme may cause harm to an unborn baby. Effective birth control methods should be used during treatment. Of all the medications you take, including prescription and over-the-counter medications, vitamins, and herbal supplements, Of your allergies, Of your health problems, Of your pregnancy status. Brexafemme may cause harm to an unborn baby. Effective birth control methods should be used during treatment.

Brexafemme (Ibrexafungerp)

Directions

Ingredients

Cautions

Side Effects